Anke Lenferink
استادیار · Chronic Obstructive Pulmonary Disease (COPD)
University of Twenteمعرفی
Anke Lenferink serves as Assistant Professor in the Health Technology & Services Research group at the University of Twente, focusing on improving care for patients with chronic respiratory conditions through evidence-based interventions. Her work bridges clinical practice and health technology to address complex challenges in chronic disease management, particularly for vulnerable patient populations requiring personalized care approaches.
Her research centers on obstructive lung disease and self-management strategies for COPD patients, investigating symptom deterioration patterns, comorbidity interactions (especially with chronic heart failure), and personalized intervention development. She examines how technological solutions and tailored care plans can enhance patient autonomy in home and clinical settings, with strong emphasis on practical implementation of self-care frameworks in real-world healthcare systems.
Recent publications reveal a clear trajectory toward precision medicine in respiratory care, moving beyond standardized protocols to individualized management strategies. Her work increasingly integrates artificial intelligence applications for symptom tracking while addressing critical gaps in home medication safety and exacerbation response. This research cluster demonstrates consistent focus on patient-centered innovation with immediate clinical applicability.
Dr. Lenferink's scholarly contributions have been recognized with prestigious awards including:
- American Thoracic Society International Trainee Scholarship (2017)
- BMS Citizenship Behaviour Award (2023)
- Longfonds Public Prize (2017)
- Lung Foundation Australia/Cochrane Airways Scholarship (2016)
- RHD Student Publication Award (2016)
She maintains active engagement with clinical communities through frequent invited presentations at major conferences like the ERS Congress, where she addresses evolving nurse competencies and personalized care frameworks for complex chronic conditions. Her collaborative approach is evident in multi-institutional studies though specific grant details and laboratory infrastructure aren't documented in available materials.
